INTEGRA LIFESCIENCES HOLDINGS CORP (IART)
Health Care / Health Care Equipment
S&P SmallCap 600$9.57
Scores poorly across most models. Proceed with caution.
Avoid
Score based on 4 of 5 models — moderate confidence
Is INTEGRA LIFESCIENCES HOLDINGS CORP a Good Investment in 2026?
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) scores 1.9 out of 10 on AlphaStocks' composite model, earning a Avoid rating. The Piotroski model rates INTEGRA LIFESCIENCES HOLDINGS CORP as Attractive (5/9). However, the Greenblatt Magic Formula model rates it Caution — Bottom half (rank 96%). INTEGRA LIFESCIENCES HOLDINGS CORP ranks #1099 out of 1127 stocks in the Health Care sector.
This summary is algorithmically generated and is not financial advice.
Key Metrics
Valuation
Currently unprofitable — fair value estimate not available.
Fair value estimate not available for this stock.
5-Model Analysis
Each model evaluates this stock from a different angle. Combined, they form the composite score above.
Piotroski
Attractive
5/9
Buffett
Caution
Business quality & competitive moat
Graham
Neutral
Price vs intrinsic value
Lynch
Neutral
Growth rate vs price (PEG)
Greenblatt
Caution
Bottom half (rank 96%)
Frequently Asked Questions
Is INTEGRA LIFESCIENCES HOLDINGS CORP (IART) a good investment?
What is INTEGRA LIFESCIENCES HOLDINGS CORP's Piotroski F-Score?
Is IART overvalued or undervalued?
How does IART compare to other Health Care stocks?
What do investment models say about IART?
Similar Stocks
Compare IART with
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer